0001104659-16-145191.txt : 20160916
0001104659-16-145191.hdr.sgml : 20160916
20160916170051
ACCESSION NUMBER: 0001104659-16-145191
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160914
FILED AS OF DATE: 20160916
DATE AS OF CHANGE: 20160916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vitae Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001157602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043567753
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 502 WEST OFFICE CENTER DR
CITY: FORT WASHINGTON
STATE: PA
ZIP: 19034
BUSINESS PHONE: 215-461-2000
MAIL ADDRESS:
STREET 1: 502 WEST OFFICE CENTER DR
CITY: FORT WASHINGTON
STATE: PA
ZIP: 19034
FORMER COMPANY:
FORMER CONFORMED NAME: Vitae Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050118
FORMER COMPANY:
FORMER CONFORMED NAME: CONCURRENT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hatfield Jeffrey S.
CENTRAL INDEX KEY: 0001609879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36617
FILM NUMBER: 161889960
MAIL ADDRESS:
STREET 1: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
a4.xml
4
X0306
4
2016-09-14
0
0001157602
Vitae Pharmaceuticals, Inc
VTAE
0001609879
Hatfield Jeffrey S.
C/O VITAE PHARMACEUTICALS, INC.
502 WEST OFFICE CENTER DR.
FORT WASHINGTON
PA
19034
1
1
0
0
Chief Executive Officer
Common Stock
2016-09-14
4
S
0
50000
20.81
D
244996
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015.
/s/ Jeffrey S. Hatfield
2016-09-16